Fate Therapeutics FATE
NASDAQ FATE
$2.37 -0.01 (-0.42%)
At close: Sep 30, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Other Non-Current Liabilities (2012 - 2026)

Updated

Fate Therapeutics (FATE) recorded Other Non-Current Liabilities of $943,000 in Q2 2026, up 194.7% from $320,000 a year earlier and up 159.8% from the prior quarter.

Analysis

Fate Therapeutics (FATE) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025, Fate Therapeutics reported Other Non-Current Liabilities of $283,000, down 46.3% from FY2024.

  • Annual Other Non-Current Liabilities has declined for four straight years, with a five-year compound annual growth rate of -52.5% (FY2020 to FY2025).
  • Across earlier years, Other Non-Current Liabilities came in at $527,000 in FY2024 (-60.8%), $1.35 million in FY2023 (-65.1%), $3.86 million in FY2022 (-84.0%) and $24.17 million in FY2021 (+106.8%).
  • The Q2 2026 figure is the highest quarterly Other Non-Current Liabilities since Q3 2024.
  • On a year-over-year basis, Other Non-Current Liabilities rose in three of the last eight quarters, with an average decline of 3.1%.
  • Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 194.7% in Q2 2026, against a decline of 92.2% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $363,000 (Q1 2026), $283,000 (Q4 2025) and $410,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Fate Therapeutics 276.57 Mn 276.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 943,000.00
Mar 31, 2026 363,000.00
Dec 31, 2025 283,000.00
Sep 30, 2025 410,000.00
Jun 30, 2025 320,000.00
Mar 31, 2025 247,000.00
Dec 31, 2024 527,000.00
Sep 30, 2024 1.20 Mn
Jun 30, 2024 1.18 Mn
Mar 31, 2024 2.74 Mn
Dec 31, 2023 1.35 Mn
Sep 30, 2023 701,000.00
Jun 30, 2023 1.75 Mn
Mar 31, 2023 2.14 Mn
Dec 31, 2022 3.86 Mn
Sep 30, 2022 9.04 Mn
Jun 30, 2022 9.93 Mn
Mar 31, 2022 15.81 Mn
Dec 31, 2021 24.17 Mn
Sep 30, 2021 24.63 Mn
API Access

Fate Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=FATE&period=max&api_key=YOUR_API_KEY